As a response to the COVID-19 crisis, LSU Health School of Medicine has initiated an effort to better understand and treat the disease. Dr. Steve Nelson, Dean of the School of Medicine, established a COVID research program that begins with the funding of pilot research grants. The COVID Biorepository has been established to be a centralized resource that collects and provides biospecimens from COVID-19 patients and uninfected control samples. Those biosamples will include plasma, serum, peripheral blood mononuclear cells, nasal swabs, nasopharyngeal swabs, saliva, and stool samples.The COVID-19 biorepository functions under standard operating procedures (SOPs), quality control for sample collection and a common database to track consent, samples and manage requests to dispense biological samples and data.

The building of the biorepository is important to:

1.      Assist  with the scientific response to the COVID-19 pandemic

2.     Foster a broad array of research projects, and will be used not only for acute, but also for longer-term studies.

3.     Create an infrastructure to help LSUHSC to be better prepared to respond appropriately to the next epidemic or pandemic.

Make a donation

Select your gift amount and click Donate Now.